Demonstrating the Value of Specialty Medications that Treat Multiple Sclerosis
There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow disease progression. Staying adherent to these costly medications is key for improving healthcare outcomes and decreasing costs, but it can be a challenge. In this second of a series of video blogs, Marly Arbuckle, senior director, specialty solutions and strategy discusses the key performance indicators that can demonstrate your members are getting the individualized care they need to achieve whole health for life, while minimizing waste and ensuring savings.
Key performance indicators that should be monitored for other specialty medications. Download our KPI Report.